The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors and the general public. “Artificial intelligence ...

The field of drug discovery faces many time-honored challenges. These include high costs, long development times and high rates of failure. The rise of artificial intelligence (AI) technology has been ...

The pharmaceutical industry is undergoing a major transformation, placing patients at the forefront of drug development like never before. This shift towards being patient-driven is reshaping the ...

For the pharmaceutical industry, drug formulation is a cornerstone, crucial for converting bioactive molecules into effective, stable, and patient-friendly medications. For the pharmaceutical industry ...

The clinical trial process is a long, expensive, complicated one that often ends in failure. This means that to have a successful outcome, careful decision making and planning are absolutely essential ...

Before a drug can reach a patient, it must go through rigorous testing to determine whether it is safe, effective at treating the condition it was developed for, and to ascertain the correct dosage ...

While no company has yet achieved the full promise of AI to radically accelerate time to market, meaningful strides are being made across the drug discovery funnel. Innovations in drug development ...

A groundbreaking type of artificial intelligence (AI) could speed up new drug development by around six years, researchers say. Cancer patients could get access to new medicines in half the current ...

Agency releases a series of new guidances to advance the reliability of patient-focused tools and methods. Ten years ago, FDA launched an initiative to expand the role of patients in informing ...

Lindus Health and Quotient Sciences have announced a strategic partnership to enable enhanced patient recruitment and ...

The author provides a review of FDA's guidance document, Guidance for Industry: Q11 Development and Manufacture of Drug Substances, and its relation to the International Conference on Harmonization's ...

G-protein coupled receptors (GPCRs) are proteins triggered by ligands (protein-binding chemicals) from outside cells to transmit signals inside the cell.